The Australian medical landscape is abuzz with the emergence of retatrutide, a groundbreaking dual GIP and GLP-1 receptor agonist showing impressive results in scientific trials for addressing obesity. https://thesocialintro.com/story7445914/retatrutide-australia-a-emerging-prospect-for-weight-management